YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Gold-backed payments, enterprise AI, a Long COVID clinical readout and AI-powered school safety lead a 6:30 p.m. ET broadcast reaching audiences across the United States, Latin America and MENA NEW YORK CITY, NY / ACCESS Newswire / Septemb…
ORLANDO, FL / ACCESS Newswire / September 18, 2026 / RedChip Companies will air interviews with Alliance Entertainment Holding Corp. (Nasdaq:AENT) and BioVie Inc. (Nasdaq:BIVI) on the RedChip Small Stocks, Big Money™ show, a sponsored tele…
BioVie CEO Cuong Do to discuss newly reported Phase 2 data showing bezisterim's potential across key Long COVID symptoms Learn why the ADDRESS-LC findings, together with recent Parkinson's data, could strengthen the case for targeting infl…
4:25pm: Broad selling pressure US stocks closed lower Tuesday as investors trimmed risk ahead of the Federal Reserve's closely watched monetary policy decision, with broad-based selling weighing on the major benchmarks. The Dow Jones Indus…
(RTTNews) - The following biotech stocks reached a 52-week high on August 12, 2026, driven up by key catalysts such as positive quarterly reports or promising results from clinical trials. BioVie Inc. (BIVI) BioVie is a clinical-stage biop…
(RTTNews) - Biotech companies are seeing significant pre-market activity this Monday. Price swings ahead of the opening bell are being driven by clinical trial and regulatory updates, as well as trial endpoint misses. In the Green - Premar…
4:20pm: S&P 500 retreats for third straight session Stocks closed lower for a third straight session on Tuesday as rising Treasury yields and lingering inflation concerns continued to pressure equities, pulling the major indexes further aw…
Appointment Strengthens Halozyme's Board as the Company Advances Its Global Drug Delivery Platform SAN DIEGO, Dec. 17, 2025 /PRNewswire/ -- Bench International today announced the appointment of Jim Lang to the Board of Directors of Halozy…
(RTTNews) - Trading after the bell was relatively muted on Thursday, with small-cap biotech names showing modest shifts. Delcath Systems edged higher following its buyback announcement, while BioVie, Cassava Sciences, and Enlivex Therapeut…
CARSON CITY, Nev., Nov. 19, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, is pleased to invit…
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In BioVie (BIVI) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder in BioVie between August 5, 2021 an…
CARSON CITY, Nev., Sept. 26, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, will host an inves…
CARSON CITY, Nev., Aug. 13, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, today announced tha…
Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume. [unusualvolume] UNUSUAL VOLUME STOCKS TICKER CHANGE COMMENT AUUD [https://www.chartmill.com/stock/quote/AUUD/profile] 22.64% The tra…
Intrigued by the market activity one hour before the close of the markets on Friday? Uncover the key winners and losers of today's session in our insightful analysis. [topmovers] TODAY'S TOP GAINERS TICKER CHANGE COMMENT MRM [https://www.c…
Investing.com -- Biovie Inc (NASDAQ:BIVI) stock plunged 43% after the clinical-stage biopharmaceutical company announced the pricing of a $12 million underwritten public offering. The offering consists of 6 million units priced at $2.00 ea…
Stay up-to-date with the latest market trends in the middle of the day on Friday. Explore the top gainers and losers during today's session in our detailed report. [topmovers] TOP GAINERS TICKER CHANGE COMMENT SGBX [https://www.chartmill.c…
The session on Friday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session. [gap] TOP GAP UP STOCKS TICKER CHANGE COMMENT ORIS [https://www.chartm…
Before the opening bell on Friday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session. [premarket] TODAY'S PRE-MARKET GAINERS TICKER CHANGE COMMENT ORIS [https://www.chartmill.com/st…
BioVie (NASDAQ:BIVI [https://seekingalpha.com/symbol/BIVI]) has priced [https://seekingalpha.com/pr/20194579-biovie-inc-announces-pricing-of-12-million-public-offering]a public offering of 6 million units at $2.00 per unit, raising approxi…
CARSON CITY, Nev., Aug. 07, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI, BIVIW), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions including liver dis…
CARSON CITY, Nev., July 24, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders an…
CARSON CITY, Nev., July 22, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders an…
Show Number 675 is sponsored programming by Ainos (NASDAQ: AIMD), Arrive AI ($ARAI), Acurx Pharmaceuticals (NASDAQ: ACXP), Sustainable Green Team (OTC: SG™) and Commercialville T.V. commercials NEW YORK CITY, NEW YORK / ACCESS Newswire / J…
CARSON CITY, Nev., June 26, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (BioVie or the Company), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and ad…
CARSON CITY, Nev., June 26, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders an…
CARSON CITY, Nev., June 24, 2025 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”) a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders an…
Featured as Sponsored Programming: FLOKI, BioVie Inc. (NASDAQ:BIVI), NRX Pharmaceuticals (NASDAQ:NRXP), and Vita Bella NEW YORK CITY, NEW YORK / ACCESS Newswire / June 16, 2025 / New to The Street, a premier financial media platform, annou…
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against BioVie Inc. (NASDAQ: BIVI) on behalf of long-term stockholders followi…
SUNRISE-PD evaluating the Company’s anti-inflammatory, insulin-sensitizing candidate bezisterim in patients with Parkinson’s disease who have not been treated with carbidopa/levodopa SUNRISE-PD is one of very few clinical trials for a Park…
PHILADELPHIA, April 08, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics Inc. (NASDAQ: AXSM) Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXS…
PHILADELPHIA, April 07, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics Inc. (NASDAQ: AXSM) Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXS…
PHILADELPHIA, April 04, 2025 (GLOBE NEWSWIRE) -- Arqit Quantum Inc. (NASDAQ: ARQQ) Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of shareholders of Arqit Quantum, Inc. (NASDAQ: ARQQ) as an und…
CARSON CITY, Nev., March 27, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders…
In this article, we will take a detailed look at the18 Best 52-Week Low Stocks To Buy Now. For a quick overview of such stocks, read our article 5 Best 52-Week Low Stocks To Buy Now. Many analysts believe US stocks are poised to grow, albe…
SAN FRANCISCO, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges BioVie Inc. (NASDAQ: BIVI) investors who suffered substantial losses to submit your losses now. Visit:www.hbsslaw.com/investor-fraud/BIVI Contact An Attorney Now:BIVI@hbs…